Technical Analysis for FRES - Fresh2 Group Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.02 | 6.05% | 0.06 |
FRES closed up 6.05 percent on Tuesday, November 19, 2024, on 42 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 6.05% | |
| 180 Bearish Setup | Bearish Swing Setup | 6.05% | |
| Narrow Range Bar | Range Contraction | 6.05% | |
| Wide Bands | Range Expansion | 6.05% | |
| Oversold Stochastic | Weakness | 6.05% | |
| Narrow Range Bar | Range Contraction | 0.99% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 21 hours ago |
| 10 DMA Resistance | about 21 hours ago |
| Up 5% | about 21 hours ago |
| Up 3% | about 21 hours ago |
| Up 2% | about 21 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 07/15/2024
Fresh2 Group Limited is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological, and genomics tests. The Company is entering the business-to-business e-commerce food business with the formation of its wholly-owned subsidiary Fresh2 Technology Inc and the acquisition of Fresh2 Ecommerce Inc.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical E Commerce Genomics Cancer Screening Medical Laboratory Science
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical E Commerce Genomics Cancer Screening Medical Laboratory Science
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.2 |
| 52 Week Low | 0.8536 |
| Average Volume | 54,932 |
| 200-Day Moving Average | 3.06 |
| 50-Day Moving Average | 1.49 |
| 20-Day Moving Average | 1.41 |
| 10-Day Moving Average | 1.13 |
| Average True Range | 0.22 |
| RSI (14) | 35.48 |
| ADX | 20.02 |
| +DI | 22.56 |
| -DI | 24.22 |
| Chandelier Exit (Long, 3 ATRs) | 1.57 |
| Chandelier Exit (Short, 3 ATRs) | 1.52 |
| Upper Bollinger Bands | 2.03 |
| Lower Bollinger Band | 0.78 |
| Percent B (%b) | 0.19 |
| BandWidth | 88.60 |
| MACD Line | -0.17 |
| MACD Signal Line | -0.12 |
| MACD Histogram | -0.0557 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.26 | ||||
| Resistance 3 (R3) | 1.28 | 1.22 | 1.22 | ||
| Resistance 2 (R2) | 1.22 | 1.16 | 1.21 | 1.21 | |
| Resistance 1 (R1) | 1.12 | 1.12 | 1.09 | 1.10 | 1.19 |
| Pivot Point | 1.06 | 1.06 | 1.05 | 1.05 | 1.06 |
| Support 1 (S1) | 0.96 | 1.00 | 0.93 | 0.94 | 0.85 |
| Support 2 (S2) | 0.90 | 0.96 | 0.89 | 0.83 | |
| Support 3 (S3) | 0.80 | 0.90 | 0.82 | ||
| Support 4 (S4) | 0.78 |
